StockNews.com started coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research report released on Tuesday. The brokerage issued a hold rating on the stock. CANF has been the subject of a number of other research reports. Alliance Global Partners boosted their target price on Can-Fite BioPharma from $8.25 to $12.00 in […]
StockNews.com assumed coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a report issued on Tuesday. The firm issued a hold rating on the stock. CANF has been the subject of a number of other research reports. HC Wainwright reduced their price objective on Can-Fite BioPharma from $34.00 to $18.00 and set a […]
StockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a report published on Tuesday morning. The brokerage issued a hold rating on the stock. Other equities analysts have also recently issued reports about the company. HC Wainwright dropped their target price on Can-Fite BioPharma from $34.00 to $18.00 and set a […]
StockNews.com started coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a report published on Monday morning. The brokerage issued a hold rating on the stock. Several other brokerages have also recently weighed in on CANF. HC Wainwright decreased their price target on shares of Can-Fite BioPharma from $34.00 to $18.00 and set […]
/PRNewswire/ DelveInsight s Vitiligo Market Insights report includes a comprehensive understanding of current treatment practices, vitiligo emerging drugs,.